Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M101712200 on June 18, 2001

J. Biol. Chem., Vol. 276, Issue 33, 30862-30870, August 17, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/33/30862    most recent
M101712200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corps, E.
Right arrow Articles by Kilshaw, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corps, E.
Right arrow Articles by Kilshaw, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Recognition of E-cadherin by Integrin alpha Ebeta 7

REQUIREMENT FOR CADHERIN DIMERIZATION AND IMPLICATIONS FOR CADHERIN AND INTEGRIN FUNCTION*

Elaine CorpsDagger , Christine CarterDagger , Paula KareclaDagger , Thomas Ahrens§, Paul EvansDagger , and Peter KilshawDagger

From the Dagger  Molecular Immunology Programme, The Babraham Institute, Babraham, Cambridge, CB2 4AT, United Kingdom and the § Department of Biophysical Chemistry, Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland

Received for publication, February 23, 2001, and in revised form, May 21, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have investigated the importance of dimerization of E-cadherin in the heterophilic adhesive interaction between E-cadherin and integrin alpha Ebeta 7. Dimerization of cadherin molecules in parallel alignment is known to be essential for homophilic adhesion and has been attributed to Ca2+-dependent interactions in the domain 1-2 junction or to cross-intercalation of Trp2 from one molecule to the other. We have disrupted either or both of these proposed mechanisms by point mutations in E-cadherin-Fc and have tested the modified proteins for alpha Ebeta 7-mediated cell adhesion. Prevention of Trp2 intercalation had no adverse effect on integrin-mediated adhesion, whereas disruption of Ca2+ binding permitted adhesion but with reduced efficiency. Both modifications in combination abolished recognition by alpha Ebeta 7. In EGTA, alpha Ebeta 7 adhered to wild type E-cadherin but not to the Trp2 deletion mutant. Independent evidence that the mutations prevented either or both mechanisms for dimerization is presented. The data show that dimerization is required for recognition by alpha Ebeta 7 and that it can take place by either of two mechanisms. Implications for the roles of the alpha E and beta 7 integrin subunits in ligand binding and for Trp2 and Ca2+ in the assembly of cadherin complexes are discussed.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

E-cadherin is a homophilic cell adhesion molecule expressed by epithelial cells. It is a type 1 transmembrane protein that contains five Ig-like extracellular domains maintained in a rodlike conformation by interdomain calcium atoms. In addition to its adhesive activity, E-cadherin has an important role as a cell signaling molecule and through both activities serves to maintain the integrity of epithelia (1). E-cadherin is also a counterreceptor for one member of the integrin family, the mucosal T cell integrin alpha Ebeta 7 (2, 3). This heterophilic adhesive interaction is thought to play a part in the retention of lymphocytes in or near mucosal epithelia (4). Recently, much attention has been focused on the molecular mechanisms for the two types of adhesion. A model has been proposed for homophilic adhesion in which adjacent cadherin molecules on the cell surface dimerize in parallel alignment (cis-dimer) and interdigitate with dimers on an opposing cell to form a zipper-like assembly of multiple low affinity contacts (5). Homophilic adhesion, heterophilic adhesion and cadherin dimerization depend mainly on contact sites on the extracellular, N-terminal domain EC1.

The mechanism for cadherin dimerization is not yet fully understood. X-ray crystallographic studies on cadherin domain 1 or domains 1 and 2 together have suggested two alternative mechanisms. Shapiro et al. (5) observed that domain 1 of N-cadherin formed cis-dimers by cross-intercalation of Trp2 into a hydrophobic pocket in its neighboring domain. In contrast, Nagar et al. (6) found that E-cadherin domains 1 and 2 dimerize through calcium-dependent hydrogen bonding in the interdomain junction. Pertz et al. (7) obtained similar results and showed that Trp2 docked into the hydrophobic pocket of its own domain rather than providing a bridge to its neighbor. The crystal structure of N-cadherin domains 1 plus 2 failed to reveal a cis-interaction by either mechanism (8). Support for Ca2+ dependence of dimerization has come from observation of purified recombinant cadherin molecules by electron microscopy (7), atomic force microscopy (9), and physical measurements of cadherin domains in solution (10). Investigations into the mechanism of cadherin dimerization on the cell surface have given a different picture. Cadherin complexes have been isolated from cell lysates and analyzed by sedimentation or electrophoresis. In this situation, Trp2 was shown to be essential for cis-dimer formation (11-14), and Ca2+ was required for the formation (15) but not the stability (12, 13, 16) of the dimers. It is not known whether the two proposed mechanisms for dimerization could operate simultaneously, but the crystal structures of ECAD1,2 (6, 7) militate against this possibility. Although the precise roles of Trp2 and interdomain calcium are not fully understood, it is widely accepted that both are required for homophilic adhesion and that cis-dimerization is an essential part of the process.

Integrin alpha Ebeta 7 has been shown to bind to the distal surface of domain 1 and the contact site has been mapped in detail. Karecla et al. (17) showed that Glu31 in the solvent-exposed CD loop was critical for recognition by the integrin. Recently, this observation has been confirmed and extended to identify a role also for the FG loop located nearby (18). Higgins et al. (19) demonstrated that these loops provide a contact surface for the A-domain of the alpha E integrin subunit. Thus, the acidic side chain of Glu31 docks into the MIDAS site of the alpha E A domain and Phe298 from the A-domain is accommodated in a hydrophobic cleft between the BC and FG loops of E-cadherin. The MIDAS site on the integrin beta 7 subunit is also required for ligand binding (19, 20) and would be expected to engage an acidic side chain from the ligand or from the alpha E subunit, but this has not been identified.

The present report examines the importance of cis-dimerization in the N-terminal domain of E-cadherin for heterophilic adhesion to alpha Ebeta 7. The two proposed mechanisms for dimer formation have been investigated. We have prepared a series of E-cadherin-Fc fusion proteins in which amino acid substitutions have been made either in the N terminus, to prevent Trp2 cross-intercalation, or in the junction between domains 1 and 2, to prevent co-ordination of one or more of the three calcium atoms present. The two categories of modification are referred to as "single" mutations or, when combined, as "double" mutations. The recombinant proteins have been tested for their ability to support alpha Ebeta 7-mediated cell adhesion and to dimerize. None of the amino acid substitutions would be expected to have any direct effect on the contact site on E-cadherin, which engages the integrin. The results show that cadherin dimerization is essential for adhesion to the integrin and provide a new perspective on the relative importance of Trp2 and the EC1-EC2 interdomain junction for the formation of cis-dimers.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Lines and Antibodies

The mouse T cell hybridoma MTC-1 was grown in RPMI 1640 supplemented with 10% FCS1 and 5 ng/ml recombinant transforming growth factor-beta 2. Under these conditions, the cells expressed high levels of alpha Ebeta 7. The mouse gut epithelial cell line CMT93, which expresses E-cadherin on the cell surface, was grown in Dulbecco's modified Eagle's medium plus 10% FCS. The rat monoclonal antibodies ECCD-2 (21) and DECMA-1 (22), specific for E-cadherin, and M290 (23), specific for mouse alpha E A-domain, were purified from culture supernatants. Sheep antisera to two peptides in E-cadherin domain 1 were prepared. The sequence spanning the beta BC loop (amino acids 25-35), KSNRDKETKVF, and that representing the distal part of the beta B strand (amino acids 19-30), KNLVQIKSNRDK, were conjugated to KLH. Sheep were immunized with the conjugates in complete Freund's adjuvant and boosted twice using incomplete adjuvant.

E-cadherin-Fc Constructs

The extracellular region of mouse E-cadherin, excluding the signal sequence and propeptide was fused to human IgG1 Fc using the vector Signal pIg-Tail (R & D Systems), which incorporates a CD33 signal sequence. The construct introduced three additional amino acids (Met, Asp, and Leu) to the N terminus of fully processed, mature E-cadherin. The extracellular region extending up to, but not including, the transmembrane domain was fused to the complete IgG1 Fc hinge. cDNA for the extracellular region of E-cadherin was prepared by polymerase chain reaction using Pfu polymerase, introducing BglII restriction sites into the 5' and 3' primers. In addition, a splice donor site was included in the 3' primer to remove an IgG1 intron so that correct splicing to the IgG1 hinge exon would take place. Forward primer was 5'-GATCAGATCTAGACTGGGTCATCCCTCCCATCAGC-3'; reverse primer was 5'-GATCAGATCTACTTACCTGTAACTTGCAATCCTGCTGCCACGATT-3'.

Constructs for wild type E-cadherin and all mutants were prepared using the QuikChange site-directed mutagenesis kit (Stratagene). Mutations were prepared in the N-terminal region, the Ca2+-binding region of EC1-2, or in both positions (Table I). Forward primers for the constructs are listed as follows and were used in conjunction with their reverse complements: wild type E-cadherin (removal of MDL from the N terminus), 5'-GCTGTGGGCAGGGGCCCTGGCTGACTGGGTCATCCCTCCCATCAGC-3'; mutation W2G/V3A (WV), 5'-GCTGTGGGCAGGGGCCCTGGCTGACGGGGCCATCCCTCCCATCAGC-3'; mutation D67A (Ca1), 5'-GGCTGAAAGTGACACAGCCTCTGGCTAGAGAAGCCATTGCC-3'; mutation Q101A/N102A (Ca2,3), 5'-GTGATCACAGTGACAGATGCGGCTGACAACAGGCCAGAG-3'; mutation D134A (Ca3), 5'-GGTCTCAGCCACCGCTGCAGACGATGACGTCAAC-3'.

In a second set of mutants, a factor Xa cleavage site (IEGR) was introduced immediately distal to the Ig hinge region: 5'-GCATGAAGGCGGGAATCGAGGGAAGAGGATTGCAAGTTACAG-3'.

All constructs were sequenced to confirm fidelity. DNA for transfection into COS cells was prepared using a Plasmid Maxi Kit (Qiagen).

Preparation of E-cadherin-Fc Fusion Proteins

COS7 cells were transfected using a modification of the DEAE-dextran method (24). After overnight recovery in Dulbecco's modified Eagle's medium plus 10% FCS, the cells were cultured in Dulbecco's modified Eagle's medium plus 1% FCS for 4-6 days. The medium was then harvested, cleared of cell debris by centrifugation at 1500 × g, and then centrifuged at 50,000 × g for 1 h. Sterile supernatants were stored at 4 °C. A representative set of E-cadherin-Fc fusion proteins (WT, MDL, WV, Ca2,3, WV + Ca2,3, and MDL + Ca2,3) were analyzed by gel filtration fast protein liquid chromatography on a Superdex-200HR 10/30 column equilibrated in 50 mM Hepes, pH 7.5, 150 mM NaCl, 0.05% Tween 20 to verify that they were monodisperse. The double mutant, Ca2,3 + WV, was susceptible to aggregation on long term storage, so particular care was taken to ensure that all experiments were conducted with monodispersed material. The double mutant was also subjected to N-terminal sequencing to ensure that no degradation had taken place. E-cadherin-Fc proteins were purified from culture supernatant by elution from protein A-Sepharose using 0.1 M glycine/HCl or 50 mM citrate, pH 3.0, followed by immediate neutralization in Tris and restoration of Ca2+ to 2 mM. Purity was verified by SDS-polyacrylamide gel electrophoresis. Concentrations were determined by adsorbance at 280 nm.

Enzyme-linked Immunosorbent Assay

The concentration of E-cadherin-Fc in culture supernatants was determined by enzyme-linked immunosorbent assay using purified E-cadherin-Fc as a standard. 96-well plates were coated overnight with affinity-purified goat anti-human Fc at 5 µg/ml in PBS. Dilutions of supernatants containing known quantities of E-cadherin-Fc were incubated on the plate for 1 h at room temperature, and their binding was detected by a similar incubation with biotinylated goat anti-human Fc (Jackson ImmunoResearch Laboratories), followed by avidin-horseradish peroxidase (Sigma). Binding of rat monoclonal antibodies DECMA-1 and ECCD-2 (both at 1 µg/ml) to E-cadherin-Fc was detected using horseradish peroxidase-labeled goat anti-rat IgG (Chemicon). For titration of sheep antibodies to the BC loop and the beta B strand, E-cadherin-Fc proteins were immobilized using rabbit anti-human Fc (Pierce), and binding of the antibodies was detected with a mouse monoclonal antibody to sheep IgG (Sigma). With both antisera, reactivity was specifically inhibited by their respective peptides.

Analytical Ultracentrifugation

Sedimentation equilibrium and sedimentation velocity experiments were performed at 20 °C using a Beckman Optima XL-A analytical ultracentrifuge (Beckman Instruments) equipped with 12-mm Epon double sector cells in an An-60 Ti rotor. The proteins were dissolved in 20 mM Tris/HCl, pH 7.9, 100 mM NaCl, and 2 mM CaCl2. The protein concentration was adjusted to 0.5 mg/ml for sedimentation equilibrium runs and to 0.15 mg/ml for the sedimentation velocity scans. Sedimentation coefficients were determined by sedimentation velocity experiments at rotor speeds of 52,000 rpm. The absorbance of the sedimenting material was measured at 232 nm. Sedimentation coefficients were corrected to standard conditions (water, 20 °C). Sedimentation equilibrium runs were carried out at 8000-17,000 rpm, depending on molecular mass. Apparent molecular masses were evaluated from lnA versus r2 plots, where A is the absorbance and r is the distance from the rotor center.

Cell Adhesion Assays

Integrin-mediated Adhesion-- E-cadherin-Fc fusion proteins were coated to a 96-well enzyme-linked immunosorbent assay plate (Costar; 3590) via goat anti-Fc as described for enzyme-linked immunosorbent assays. MTC-1 cells were labeled with BCECF-AM (Molecular Probes catalog no. B-3051) by incubation in 1 ml of serum-free RPMI containing 5 µg/ml BCECF-AM for 30-40 min at 37 °C. The cells were then washed and resuspended at 5 × 105/ml in assay medium, HBSS (Sigma) containing 1.25 mM Ca2+ and 0.8 mM Mg2+ plus 1% FCS. The cells were then activated by the addition of phorbol 12-myristate 13-acetate (15 ng/ml). 5 × 104 cells were added to each well in a total volume of 200 µl. The plate was centrifuged for 2 min at 16 × g to gently sediment the cells and then incubated at 37 °C for 30 min. Nonadherent cells were then removed by gentle pipetting, and the attached cells were quantitated using a fluorescence plate reader. For assays conducted in the absence of Ca2+, MTC-1 cells were suspended in Hanks' balanced saline solution plus 0.1% bovine serum albumin, activated with phorbol 12-myristate 13-acetate, and then washed free of Ca2+ and transferred to Hanks' balanced saline solution lacking Ca2+ and Mg2+, supplemented with 0.1% bovine serum albumin, 1 mM EGTA, and 10 mM Mg2+. For experiments involving antibody-mediated inhibition of adhesion, purified IgG antibodies (DECMA-1, ECCD2, M290) were present in the adhesion assay at 10 µg/ml (DECMA-1 and ECCD2) or 2.5 µg/ml (M290). Adhesion results are expressed as mean percentage of cells adhering in three or four replicate wells ± S.E.

Homophilic Adhesion-- E-cadherin-Fc fusion proteins were attached to assay plates as described above. CMT93 cells were dissociated by chelation (nonenzymatic cell dissociation solution; Sigma) and maintained in suspension in Dulbecco's modified Eagle's medium plus 10% FCS at 37 °C for 20 min. They were then transferred to Hanks' balanced saline solution plus 1% FCS, and 8 × 104 cells were added to each well. The plates were then incubated at 37 °C for 30 min. Nonadherent cells were washed away, and residual adherent cells were quantitated by measuring acid phosphatase activity (25).

Cleavage with Factor Xa

1-2 µg of E-cadherin-Fc bound to 10 µl of protein A-Sepharose was suspended in 50 µl of 100 mM NaCl, 2 mM CaCl2, 20 mM Tris/HCl, pH 8.0. 1 µg of factor Xa (1 µl at 1 mg/ml; New England Biolabs) was added and incubated at room temperature for 5 h. Released cadherin fragments were separated by SDS-polyacrylamide gel electrophoresis and analyzed by Western blotting using DECMA-1. Residual IgFc on the beads was released with SDS sample buffer and analyzed by Western blotting using anti-Fc.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Production and Characterization of Wild Type and Mutant E-cadherin-Fc Proteins-- Table I lists the two categories of E-cadherin mutations: calcium loss mutants and N-terminal modifications that affect Trp2 intercalation. A third group of E-cadherin-Fc molecules was prepared in which the two types of mutation were combined (double mutants). Analytical ultracentrifugation experiments were performed to determine molecular masses and sedimentation coefficients of wild type E-cadherin-Fc and the double mutant, WV + Ca2,3. These proteins represent the two most extreme situations with respect to possible conformational differences. The sedimentation coefficients of the wild type and mutant were closely similar (Table II), which implies that their frictional coefficients were also similar. Because the shapes proposed for these molecules are complex, these data do not distinguish between the presence or absence of cis-dimerization of cadherin chains within the Fc fusion proteins. Sedimentation equilibrium experiments for molecular mass determinations were performed at 17,000 rpm and 8000 rpm. At 17,000 rpm, both wild type and mutant proteins were monodisperse (Table II). In contrast, sedimentation of the wild type protein at a lower speed, 8000 rpm, showed the presence of a predominant species with an apparent molecular mass of 441 kDa, which is likely to represent E-cadherin-Fc molecules joined in pairs by a low affinity adhesive trans-interaction. Conversely, the double mutant, which would not be expected to be active in homophilic adhesion, gave a heterogeneous mixture of species at 202 and 400 kDa. Although it is not possible to quantify precisely the two subpopulations, we conclude that the ability of the mutant protein to form trans-interactions was greatly impaired. We emphasize that the concentration of E-cadherin-Fc proteins used in adhesion assays was ~100-fold lower than that used for ultracentrifugation, and under these circumstances all of the preparations were monodisperse.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Mutations prepared in E-cadherin-Fc

                              
View this table:
[in this window]
[in a new window]
 
Table II
Sedimentation Coefficients and Molecular Masses of E-cadherin-Fc WT and the double mutant E-cadherin-Fc WV + Ca2,3 determined by analytical ultracentrifugation

alpha Ebeta 7-dependent Adhesion of MTC-1 Cells to Wild Type or Mutant E-cadherin-Fc Fusion Proteins-- Fig. 1a illustrates the basic parameters of the integrin-mediated adhesion assay and shows adhesion of MTC-1 cells to wild type E-cadherin-Fc adsorbed to an assay plate via anti-human Fc. Adhesion was completely inhibited by the anti-mouse E-cadherin antibody ECCD2 and by the alpha E-specific antibody M290, which recognizes the alpha E A-domain.2 The antibody DECMA-1, specific for E-cadherin domain 4, had no effect on integrin-mediated adhesion. Mutant proteins were then compared with wild type for their ability to support alpha Ebeta 7-mediated adhesion (Fig. 1b). The MDL and WV mutants had no effect on adhesion; nor did these two modifications in combination. The mutations Ca1, Ca2,3, and Ca3 supported adhesion but with reduced efficiency. In contrast, double mutants, in which modifications to the N terminus were combined with the Ca2+ loss mutations, failed to support adhesion. Fig. 1c shows that all types of mutation completely abrogated homophilic adhesion of CMT93 cells to the E-cadherin-Fc proteins. To gain a more complete picture of the effects of the mutations on alpha Ebeta 7-mediated adhesion, some of the mutant proteins were titrated in the integrin-dependent adhesion assay (Fig. 2). The titration curve given by the WV mutant was identical to that of wild type E-cadherin-Fc (Fig. 2a). In contrast, the mutants Ca2,3 and Ca3 supported adhesion less efficiently and titrated to background levels of adhesion at higher coating levels than those observed with wild type E-cadherin (Fig. 2b). Ca1 behaved similarly (Fig. 2c). These results are taken from separate experiments, and the differences in adhesion to wild type E-cadherin reflect interassay variation commonly experienced in cell adhesion tests of this type, due mainly to variation in the levels of alpha Ebeta 7 expressed by the MTC-1 cells. Our results with mutants that adversely affect Ca2+ coordination are broadly consistent with an earlier report that alpha Ebeta 7 can adhere to E-cadherin-Fc in the absence of Ca2+ (26). We have observed that Ca2+-independent adhesion of wild type E-cadherin could be obtained by activating the integrin with 10 mM Mg2+. Prestimulation of the cells with phorbol 12-myristate 13-acetate before adhesion in the presence of EGTA maximized the adhesion obtained. Fig. 3 compares integrin-mediated adhesion with wild type E-cadherin Fc and with the WV mutant, in the presence of EGTA and 10 mM Mg2+. Approximately 50% of MTC-1 cells adhered to wild type E-cadherin, but adhesion to the WV mutant was negligible. This result is consistent with the view that intercalation of Trp2 provides a mechanism for dimer formation when Ca2+ is lacking. Taken together, the results from cell adhesion tests suggest that cis-dimerization of E-cadherin by either mechanism is required for recognition by alpha Ebeta 7 but that dimerization mediated by Ca2+ in the EC1-EC2 junction gives the preferred conformation.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Cell adhesion to E-cadherin-Fc proteins. Wild type or mutant proteins were coated onto an assay plate (0.5 µg/ml) and tested for integrin-mediated or homophilic cell adhesion. a, alpha Ebeta 7-mediated adhesion of MTC-1 cells showing the effect of blocking antibodies specific for E-cadherin (DECMA-1 and ECCD-2) or alpha E (M290); b, alpha Ebeta 7-mediated adhesion of MTC-1 cells to wild type E-cadherin-Fc and the panel of mutants; c, homophilic adhesion of CMT93 epithelial cells to wild type E-cadherin-Fc and the panel of mutants. The negative control was provided by wells coated with R-cadherin-Fc. Results are expressed as mean values ± S.E. from three or four replicates.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2.   Ca2+ loss mutants support alpha Ebeta 7-mediated adhesion less efficiently than WT or N-terminal mutants. Plates were coated with increasing levels of E-cadherin-Fc proteins. a, adhesion of MTC-1 cells to WT and WV was closely similar. In contrast, the Ca2+ loss mutants, Ca2,3 and Ca3 (b) and Ca1 (c), were markedly inferior to WT in supporting integrin-mediated adhesion. Results show the mean percentage of cells adhering in three or four replicate wells ± S.E.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   In EGTA, WT E-cadherin-Fc supports integrin-mediated adhesion, but the Trp2 replacement mutant does not. MTC-1 cells were activated with phorbol 12-myristate 13-acetate and 10 mM Mg2+ and tested for adhesion to WT or WV E-cadherin Fc proteins. Cells adhered to the WT protein but not to the WV mutant.

Antibodies to Domain 1 Peptides Distinguish Monomers from Dimers-- Although recognition of E-cadherin dimers by alpha Ebeta 7 provides a plausible explanation for our results, there remained a less likely alternative possibility that Ca2+ in the EC1-EC2 junction, or Trp2 in the beta A strand could each mediate distant effects on the conformation of the BC loop that would influence integrin binding. We have addressed this issue through the use of two antisera to peptides in domain 1, one antiserum to a peptide spanning the BC loop and a second to part of the beta B strand (Fig. 4). The amino acid sequence of the latter lies in a cleft at the interface between the two juxtaposed EC1 domains and, in dimeric E-cadherin, would be inaccessible to antibodies. The antisera were tested against wild type or mutant proteins in the presence of varying levels of Ca2+ or in EGTA. Fig. 5 shows that the two antisera behaved similarly; reactivity of anti-BC is shown in Fig. 5a, and reactivity of anti-beta B is shown in Fig. 5b. The WT and Ca2,3 proteins were not recognized by peptide-specific antibodies regardless of the presence or absence of Ca2+. In contrast, the double mutant (WV + Ca2,3), in which both mechanisms for dimerization were absent, was recognized by both antibodies under all conditions. The behavior of the WV mutant in these assays depended on the level of Ca2+. No binding was detected in the presence of 1.25 mM or 0.5 mM Ca2+, but, when the concentration was reduced to 0.125 mM, weak reactivity was just detectable, and in Ca2+-free Tris or EGTA, antibody binding was maximal. The similar behavior of the two antibodies can be explained by the inability of either of them to recognize dimeric E-cadherin. The beta B epitope was selected specifically to be inaccessible in the dimer, but the epitope on the BC loop is exposed. Molecular modeling with cadherin dimers and Fab fragments (not shown) strongly suggests that access by an IgG molecule to the BC loop would be compromised in the dimer by the close proximity of the two EC1 domains.


View larger version (82K):
[in this window]
[in a new window]
 
Fig. 4.   Location of peptides in E-cadherin domain 1 used to produce antisera. a, the amino acid sequence, KSNRDKETKVF, which spans the BC loop (the underlined E is Glu31); b, the sequence KNLVQIKSNRDK, which covers the beta B strand. The structure of the EC1,2 dimer is taken from Pertz et al. (7).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   Reactivity of E-cadherin-Fc proteins with two peptide antisera in varying concentrations of calcium. a, antiserum to the BC loop; b, antiserum to the beta B strand. Antibody binding tests were performed in EGTA (), Ca2+-free TBS (open circle ), 0.125 mM Ca2+ (black-square), 0.5 mM Ca2+ (black-triangle), or 1.25 mM Ca2+ (). Both antisera recognized the cadherin monomer only.

Conformational Changes in E-cadherin-Fc Proteins-- A Factor Xa cleavage site was introduced into wild type and five mutant E-cadherin Fc proteins, immediately distal to the three disulfide bonds of the Ig hinge, to allow release of the extracellular domains of E-cadherin. The presence of this site had no effect on the functional activity of the proteins in heterophilic or homophilic adhesion tests nor on reactivity with our peptide-specific antibodies. All of the preparations were shown to be monodisperse by fast protein liquid chromatography. We observed striking, consistent differences in the digestion products of the mutant Fc fusion proteins following treatment with factor Xa. The pattern correlated with the ability of the mutants to support alpha Ebeta 7-mediated adhesion and to form dimers. Fig. 6a shows a Western blot of the digestion products seen with our panel of mutants. Introduction of the cleavage site into WT E-cadherin caused factor Xa to release an 86-kDa fragment corresponding to the EC1-5. A similar pattern was seen with the MDL and WV mutants. In contrast, the Ca2,3 mutant gave a closely spaced double band at ~170 kDa in addition to the expected product at 86 kDa. The double mutants, WV + Ca2,3 and MDL + Ca2,3, gave a single band at 170 kDa and the expected 86-kDa product. Upon reduction, all digestion products were resolved at 86 kDa (Fig. 6b). These results demonstrate that factor Xa cleaved some of the mutants at nonspecific sites near the Ig hinge, in close proximity to the expected position, to give a 170-kDa disulfide-bonded product. Analysis of the residual material remaining on the Sepharose beads after digestion (i.e. the remaining IgFc) gave a 50-kDa band before reduction (Fig. 6c) and a 25-kDa band after reduction (Fig. 6d), demonstrating that the aberrant cleavage sites were within the Ig hinge and were flanked on either side by disulfide bonds. The patterns of cleavage shown in Fig. 6 were seen in all experiments performed and with separate preparations of the E-cadherin-Fc proteins. We attribute the altered pattern of cleavage to major conformation changes in the proteins, specifically to the introduction of greater segmental flexibility and dynamic freedom in the hinge region caused by failure of cis-dimer formation by the double mutants. In the case of the Ca2,3 mutant, which we argue is dimerized by Trp2 cross-intercalation, the loss of Ca2+ at the EC1-EC2 junction would introduce freedom of movement between EC1 and EC2 (27), and, because the other domain junctions in the cadherin molecule are relatively rigid, this increased freedom would be transmitted to the Ig hinge. In this case, two closely spaced aberrant factor Xa cleavage sites were present. In effect, loss of interdomain Ca2+ or failure of dimerization at the level of domain 1 causes the molecule to flex more at the hinge. Cleavage by factor Xa is acting as a sensitive indicator of conformational change. Nonspecific cleavage by factor Xa is known to occur in regions of high flexibility and at lysyl residues (28, 29); both criteria are fulfilled in the circumstances of our experiments. Cumulative evidence from the present results and from previous studies on the role of Ca2+ and Trp2 in dimer formation suggests that our E-cadherin-Fc proteins adopt the conformations proposed in Fig. 7.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Cleavage of E-cadherin-Fc proteins with factor Xa reflects conformational changes in the IgFc hinge. A factor Xa cleavage site (FXa) was introduced into the N-terminal side of the IgFc hinge in our panel of proteins. The products released after digestion with factor Xa were separated by SDS-polyacrylamide gel electrophoresis under nonreducing (a) or reducing (b) conditions and were detected by Western blotting with DECMA-1. WT E-cadherin-Fc lacking a factor Xa site was not cleaved by factor Xa (left-hand track). In the other proteins, the band at ~86 kDa represents E-cadherin EC1-EC5. The products at ~170 kDa are paired EC1-EC5 units joined together by disulfide bonds within the IgFc hinge. The paired EC1-EC5 units became separated upon reduction (b). The result shows that aberrant cleavage occurred in E-cadherin-Fc proteins in which dimerization via EC1 had failed or was maintained by Trp2 only. Residual IgFc remaining after release of EC1-EC5 was separated under nonreducing (c) or reducing (d) conditions and detected by blotting with anti-Fc; products were present at 50 and 25 kDa, respectively, representing disulfide-bonded or single Fc chains. This result confirms that aberrant cleavage occurred at sites within the Ig hinge, flanked on either side by disulfide bonds. The high MW bands in c and d represent small amounts of residual intact or partially digested E-cadherin-Fc remaining on the beads.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Proposed structures of the wild type and mutant E-cadherin-Fc proteins. The model on the left shows the Ca2+-dependent dimer, which has a relatively firm structure with little flexibility at the EC1-EC2 junction. The center model shows the Trp2-dependent dimer, which has lost rigidity at the EC1-EC2 junction when Ca2+ is lacking here and therefore is permitted flexibility in the directions of the arrows. The third model has lost the capacity to dimerize and shows free flexibility at the Ig hinge. All models would be expected to show some flexibility also at right angles to the plane of the paper. Positions of the factor Xa cleavage site and the three disulfide bonds are shown.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The primary aim of this study was to determine whether cis-dimerization of E-cadherin is required for recognition by alpha Ebeta 7. We chose E-cadherin-Fc proteins for the analysis because the disulfide bonds of the Ig hinge would hold the membrane-proximal regions of paired cadherin molecules in close apposition. This may simulate the situation on the cell membrane when regulatory mechanisms acting on the cytoplasmic domain favor cadherin clustering (30, 31). Huber et al. (32) have demonstrated that transmembrane segments of E-cadherin cluster together, possibly by a leucine zipper-type mechanism, and have proposed that this mechanism acts in concert with cis-interactions at domain 1 to stabilize the dimer. At low Ca2+ concentrations, other ectodomains may also be involved (33). We have focused specifically on cis-interactions at domain 1. The mutations in the N-terminal region of domain 1 and in the Ca2+ binding sites in the EC1-EC2 junction were selected to investigate the two proposed mechanisms for dimerization. We extended the N terminus by three amino acids, MDL, because this would be expected to interfere with the cross-intercalation of Trp2 between domain pairs (5) or docking into its own domain (7). As predicted, results with this mutant were identical to those with the WV mutant and are consistent with previous reports that correct cleavage of the N terminus (34) and the presence of Trp2 (12, 13,) are both essential for cadherin function. Mutations of amino acids coordinating Ca1, Ca2,3, or Ca3 were selected by reference to two published crystal structures (6, 7) and a previous report (35) that the Ca3 mutant (Asp134 right-arrow Ala) prevents homophilic adhesion. The Ca2,3 mutant (Q101A/N102A) removed Gln101, which is thought to play a key role in hydrogen bonding between the domain pair (6). The binding site for Ca1 was targeted because it is thought to have a lower affinity for Ca2+ than the other two sites (7, 27) and to be required for homophilic adhesion but not dimer formation (7). Our results with Ca1 were, however, similar to those with the other two calcium loss mutants. Calcium binding has not yet been measured empirically in these mutants, so it is not absolutely certain that we achieved selectivity for particular calcium atoms; loss of a single calcium ligand may have destabilized the junctional region as a whole.

Prevention of Trp2 intercalation alone was shown to have no effect on integrin-mediated adhesion, and loss of one or more calcium atoms in the EC1-EC2 junction permitted alpha Ebeta 7-mediated adhesion but with reduced efficiency. The two types of modification in combination completely prevented adhesion, which implies that integrity of one or the other mechanism for dimerization was required. A reciprocal relationship between Trp2 and interdomain Ca2+ was confirmed by the observation that integrin-mediated adhesion in the presence of EGTA was abrogated by the removal of Trp2.

Binding of peptide antibodies specific for the BC loop or the beta B strand strongly supports our contention that dimers can form by either mechanism. The antibodies bound to double mutants, which should not form dimers, but did not bind to wild type or single mutants in which dimerization would be expected. Experiments with the Trp2 replacement mutant, WV, demonstrated that the Ca2+-dependent mechanism required Ca2+ concentrations higher than 125 µM. At this level, the first indication of dissociation into monomers was detected.

Attempts to monitor dimerization by chemical cross-linking experiments with E-cadherin-Fc have been unsuccessful for technical reasons. Similarly, electron microscopic observations on the proteins have been confounded by disruption of the dimeric conformation during the preparative procedures. Nevertheless, our studies with factor Xa proteolysis have provided additional evidence for major conformational changes consistent with the presence of absence of dimers. Generation of nonspecific cleavage products in the IgFc hinge using factor Xa can be adequately explained by differences in flexibility at the Ig hinge related to dimerization at the level of EC1. To our knowledge, this is a novel use of a restriction peptidase to monitor conformational changes in a protein.

Another laboratory recently reported that dimerization of E-cadherin was unnecessary for either alpha Ebeta 7-mediated adhesion or homophilic adhesion (36). The authors observed that unmodified E-cadherin-Fc fusion protein that had been reduced and alkylated in the Ig hinge and was assumed to be monomeric functioned normally in either type of assay. The interpretation is, however, flawed, because in these circumstances strong noncovalent interactions between the CH3 domains of the paired Fc regions would have maintained the dimeric structure (37, 38).

Implications for Integrin Function-- In principal, a dimeric ligand could either bind two separate integrin molecules by monovalent interactions or one integrin molecule in a bivalent manner. Recent studies on the crystal structure of the ICAM-1 dimer suggest that monovalency is likely in the interaction with LFA-1 (39). The critical Glu34 integrin contact residues in the ICAM-1 dimer are located on outward facing surfaces on opposite sides of the molecule a maximum distance apart, about 4.2 nm (39). In contrast, the two Glu31 residues that lie side by side on the top surface of dimeric E-cadherin and are recognized by alpha Ebeta 7 are more closely spaced, about 2.4 nm apart. A convincing model has recently been proposed for the interaction between the A-domain of the alpha E integrin subunit and the top surface of E-cadherin domain 1, involving docking of E-cadherin Glu31 into the alpha E MIDAS site (19). It is doubtful whether two alpha E A-domains could dock simultaneously onto the E-cadherin dimer. Additional steric constraints imposed by the beta -propeller of the alpha -subunit and the presence of the beta 7 subunit in the intact integrin would make this stoichiometry highly unlikely. An alternative explanation is that contact residues from each component of the EC1 domain pair are recognized by a single alpha Ebeta 7 molecule. If so, the spatial relationships between the exposed acidic side chains on the top surfaces of the two cadherin molecules would be critical for integrin binding. The Ca2+-dependent dimer would present the paired recognition sites in a relatively firm structure. By contrast, the Trp2-dependent dimer would permit freedom of movement of the two EC1 domains relative to one another, which would compromise correct spacing of the contact sites. This could explain why integrin binding was less efficient in the Ca2+ loss mutants.

It is clear from mutagenesis studies (19) and from epitope mapping of blocking antibodies (20, 40) that the A-like domain of the beta 7 subunit, especially the MIDAS cleft within it, is essential for cadherin recognition. It is possible that the A-like domain of the beta 7 subunit may dock to an acidic side chain on the top surface of one component of the dimer, while the alpha E A-domain engages Glu31 from the other component. Direct evidence for this is not yet available. It has been proposed that, in general, the integrin beta -subunit A-like domain functions to regulate ligand-binding by the A-domain of the alpha -subunit and, in integrins that lack an alpha -subunit A-domain, directly participates in ligand binding (41). Structural models have been proposed for both situations (41, 42). Recent experiments in which the alpha L A-domain has been locked by mutagenesis into an "open" conformation have shown that the ligand binding activity of LFA-1 is attributable entirely to the alpha  chain A-domain and that the beta  subunit performs a regulatory role (43, 44). In suggesting ligand engagement by both alpha  and beta  subunits, we envisage that alpha E may be a special case. Why should this be so? The alpha Ebeta 7 integrin is unusual in two respects. First, expression is normally confined to intraepithelial lymphocytes in the gut, a population of highly cytotoxic, potentially self-reactive, effector T cells specialized for a local tissue-specific function (45). Second, only one ligand, E-cadherin, has been identified for alpha Ebeta 7. Recently, weak cadherin-independent binding to an unidentified ligand on intestinal microvascular endothelial cells has also been reported (46), but the physiological significance of this is not clear. Tightly restricted ligand-binding specificity may be necessary for alpha Ebeta 7 because it is important that potentially autoreactive mucosal T cells be retained in their correct location. Ligand recognition requiring ligand contact by both integrin subunits would provide a mechanism for ensuring more precise specificity than that seen in other integrins. A recent report that alpha E-deficient mice develop an inflammatory skin disorder (47) is consistent with the idea that correct tissue compartmentalization of these effector T cells is important.

Two Mechanisms for Cis-dimerization-- Evidence on the role of Ca2+ in cis-dimerization is complex and partly conflicting. The average dissociation constant for calcium binding in the junction between domains 1 and 2 has been variously estimated to be 23 µM (10) and 460 µM (27), and it is possible that one calcium atom is bound with much lower affinity, 2 mM (27). The higher values are in a range at which physiological changes in extracellular calcium, as a consequence, for example, of the operation of calcium channels in the cell membrane, could regulate calcium binding at the EC1-EC2 junction and modulate adhesion. Pertz et al. (7) have proposed a model for homophilic adhesion in which cis-dimerization occurs entirely in a Ca2+-dependent manner and Trp2 intercalates into its own domain. The insertion of Trp2 causes a conformational change on the beta CFG surface that is required for an adhesive trans-interaction with E-cadherin on an opposing cell. The model predicts that reduction in Ca2+ concentration to ~500 µM will release Trp2 from the hydrophobic pocket with consequent loss of homophilic adhesion. On the basis of our present data, we propose an alternative model. In this case, cis-dimerization in an isolated dimeric molecule is maintained primarily by calcium atoms at the domain 1-2 junction. Structural constraints imposed by Ca2+ favor intercalation of Trp2 into its own domain. If Ca2+ levels are reduced, one or more of the interdomain calcium atoms are lost, and the EC1-EC2 junction becomes more flexible. Trp2 then cross-intercalates to maintain the dimer. The adhesive trans-interaction, which occurs in the presence of Ca2+, may also modify the orientation of the EC1 domains sufficiently to encourage Trp2 cross-intercalation. Thus, the function of Ca2+ is to initiate formation of the dimer and to hold the domain junction rigid for the trans-interaction to take place. The primary role of Trp2 is to maintain the dimeric structure in the adhesive complex. Our experiments show that the Trp2 dimer is very stable and is maintained even when the whole cadherin molecule collapses as a result of calcium chelation.

The present data have helped to reconcile two seemingly conflicting views on the mechanism of E-cadherin dimerization by showing that both are valid and may reflect different phases in the assembly of cadherin complexes.

    ACKNOWLEDGEMENT

We are very grateful to Dr Ariel Lustig (Biozentrum, University of Basel) for performing analytical ultracentrifugation experiments.

    FOOTNOTES

* This work was supported by the Biotechnology and Biological Sciences Research Council, UK.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: The Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom. Tel.: 44 1223 496553; Fax: 44 1223 496023; E-mail: peter.kilshaw@bbsrc.ac.uk.

Published, JBC Papers in Press, June 18, 2001, DOI 10.1074/jbc.M101712200

2 P. Kilshaw, unpublished results.

    ABBREVIATIONS

The abbreviations used are: FCS, fetal calf serum; WT, wild type.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Vleminckx, K., and Kemler, R. (1999) Bioessays 21, 211-220
2. Cepek, K. L., Shaw, S. K., Parker, C. M., Russell, G. J., Morrow, J. S., Rimm, D. L., and Brenner, M. B. (1994) Nature 372, 190-193
3. Karecla, P. I., Bowden, S. J., Green, S. J., and Kilshaw, P. J. (1995) Eur. J. Immunol. 25, 852-856
4. Schon, M. P., Arya, A, Murphy, E. A., Adams, C. M., Strauch, U. G., Agace, W. W., Marsal, J., Donohue, J. P., Her, H., Beier, D. R., Olson, S., Lefrancois, L., Brenner, M. B., Grusby, M. J., and Parker, C. M. (1999) J. Immunol. 162, 6641-6649
5. Shapiro, L., Fannon, A. M., Kwong, P. D., Thompson, A., Lehmann, M. S., Grubel, G., Legrand, J-F, Als-Nielsen, J., Colman, D. R., and Hendrickson, W. A. (1995) Nature 374, 327-337
6. Nagar, B., Overduin, M., Ikura, M., and Rini, J. M. (1996) Nature 380, 360-364
7. Pertz, O., Bozic, D., Koch, A. W., Fauser, C., Andrea Brancaccio, A., and Engel, J. (1999) EMBO J. 18, 1738-1747
8. Tamura, K., Shan, W-S., Hendrickson, W. A., Colman, D. R., and Shapiro, L. (1998) Neuron 20, 1153-1163
9. Baumgartner, W., Hinterdorfer, P., Ness, W., Raab, A., Vestweber, D., Schindler, H., and Drenckhahn, D. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4005-4010
10. Alattia, J-R., Ames, J. B., Porumb, T., Tong, K. I., Heng, Y. M., Ottensmeyer, P., Kay, C. M., and Ikura, M. (1997) FEBS Lett. 417, 405-408
11. Shan, W-S., Tanaka, H., Phillips, G. R., Arndt, K., Yoshida, M., Colman, D. R., and Shapiro, L. (2000) J. Cell Biol. 148, 579-590
12. Chitaev, N. A., and Troyanovsky, S. M. (1998) J. Cell Biol. 142, 837-846
13. Kitagawa, M., Natori, M., Murase, S., Hirano, S., Taketani, S., and Suzuki, S. T. (2000) Biochem. Biophys. Res. Commun. 271, 358-363
14. Klingelhofer, J., Troyanovsky, R. B., Laur, O. Y., and Troyanovsky, S. (2000) J. Cell Sci. 113, 2829-2836
15. Takeda, H., Shimoyama, Y., Nagafuchi, A., and Hirohashi, S. (2000) Nat. Struct. Biol. 6, 310-312
16. Brieher, W. M, Yap, A. S., and Gumbiner, B. M. (1996) J. Cell Biol. 135, 487-496
17. Karecla, P. I., Green, S. J., Bowden, S. J., Coadwell, J., and Kilshaw, P. J. (1996) J. Biol. Chem. 271, 30909-30915
18. Taraszka, K. S., Higgins, J. M. G., Tan, K., Mandelbrot, D. A., Wang, J. H., and Brenner, M. B. (2000) J. Exp. Med. 191, 1555-1567
19. Higgins, J. M. G., Cernadas, M., Tan, K., Irie, A., Wang, J. H., Takada, Y., and Brenner, M. B. (2000) J. Biol. Chem. 275, 25652-25664
20. Tidswell, M., Pachynski, R., Wu, S. W., Qui, S. Q., Dunham, E., Cochran, N., Briskin, M. J., Kilshaw, P. J., Lazaovits, A. I., Andrew, D. P., Butcher, E. C., Yednock, T. A., and Erle, D. J. (1997) J. Immunol. 159, 1497-1505
21. Sirayoshi, Y., Nose, A., Iwasaki, K., and Takeichi, M. (1986) Cell Struct. Funct. 11, 245-252
22. Ozawa, M., Hoshutzky, H., Herrenknecht, K., and Kemler, R. (1990) Mech. Dev. 33, 49-56
23. Kilshaw, P. J., and Baker, K. C. (1988) Immunol. Lett. 18, 149-154
24. Gonzalez, A. L., and Joly, E. (1995) Trends Genet. 11, 216-217
25. Tolosa, E., and Shaw, S. (1996) J. Immunol. Methods 192, 165-172
26. Higgins, J. M. G., Mandelbrot, D. A., Shaw, S. K., Russell, G. J., Murphy, E. A., Chen, Y. T., Nelson, W. J., Parker, C. M., and Brenner, M. B. (1998) J. Cell Biol. 140, 197-210
27. Koch, A. W., Pokutta, S., Lustig, A., and Engel, J. (1997) Biochemistry 36, 7697-7705
28. Wearne, S. J. (1990) FEBS Lett. 263, 23-26
29. Nakashima, A., Mori, K., Nagatsu, T., and Ota, A. (1999) J. Neural Transm. 106, 819-824
30. Ozawa, M., and Kemler, R. (1998) J. Cell Biol. 142, 1605-1613
31. Ozawa, M., and Kemler, R. (1998) J. Biol. Chem. 273, 6166-6170
32. Huber, 0., Kemler, R., and Langosch, D. (1999) J. Cell Sci. 112, 4415-4423
33. Troyanovsky, R. B., Klingelhofer, J., and Troyanovsky, S. (1999) J. Cell Sci. 112, 4379-4387
34. Ozawa, M., and Kemler, R. (1990) J. Cell Biol. 111, 1645-1650
35. Ozawa, M., Engel, J., and Kemler, R. (1990) Cell 63, 1033-1038
36. Berg, R. W., Yang, Y., Lehnert, K., and Krissansen, G. W. (1999) Immunol. Cell Biol. 77, 337-344
37. Thies, M. J., Mayer, J., Augustine, J. G., Frederick, C. A., Lilie, H., and Buchner, J. (1999) J. Mol. Biol. 293, 67-79
38. Dall'Acqua, W., Simon, A. L., Mulkerrin, M. G., and Carter, P. (1998) Biochemistry 37, 9266-9273
39. Casasnovas, J. M., Stehle, T., Liu, J-H., Wang, J. H., and Springer, T. A. (1998) Proc. Natl. Acad. Sci. 95, 4134-4139
40. Andrew, D. P., Berlin, C., Honda, S., Yoshino, T., Hamann, A., Holzmann, B., Kilshaw, P. J., and Butcher, E. C. (1994) J. Immunol. 153, 3847-3861
41. Zang, Q., Lu, C., Huang, C., Takagi, J., and Springer, T. A. (2000) J. Biol. Chem. 275, 22202-22212
42. Purzon-McLaughlin, W., Kamata, T., and Takada, Y. (2000) J. Biol. Chem. 275, 7795-7802
43. Lu, C., Shimaoka, M., Ferzly, M., Oxvig, C., Takagi, J., and Springer, T. A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 2387-2392
44. Lu, C., Shimaoka, M., Zang, Q., Takagi, J., and Springer, T. A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 2393-2398
45. Beagley, K. W., and Husband, A. J. (1998) Crit. Rev. Immunol. 18, 237-254
46. Strauch, U. G., Mueller, R. C., Li, X. Y., Cernadas, M., Higgins, J. M. G., Binion, D. G., and Parker, C. M. (2001) J. Immunol. 166, 3506-3514
47. Schon, M. P., Schon, M., Warren, H. B., Donohue, J. P., and Parker, C. M. (2000) J. Immunol. 165, 6583-6589


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JEMHome page
A. L. Floc'h, A. Jalil, I. Vergnon, B. L. M. Chansac, V. Lazar, G. Bismuth, S. Chouaib, and F. Mami-Chouaib
{alpha}E{beta}7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis
J. Exp. Med., March 19, 2007; 204(3): 559 - 570.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. G. Kan, M. P. Stemmler, D. Junghans, B. Kanzler, W. N. de Vries, M. Dominis, and R. Kemler
Gene replacement reveals a specific role for E-cadherin in the formation of a functional trophectoderm
Development, January 1, 2007; 134(1): 31 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. A. Lovett, I. Gonzalez, D. A. M. Salih, L. J. Cobb, G. Tripathi, R. A. Cosgrove, A. Murrell, P. J. Kilshaw, and J. M. Pell
Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation
J. Cell Sci., December 1, 2006; 119(23): 4828 - 4840.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. J. Harrison, E. M. Corps, and P. J. Kilshaw
Cadherin adhesion depends on a salt bridge at the N-terminus
J. Cell Sci., September 15, 2005; 118(18): 4123 - 4130.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Shiraishi, K. Tsuzaka, K. Yoshimoto, C. Kumazawa, K. Nozaki, T. Abe, K. Tsubota, and T. Takeuchi
Critical Role of the Fifth Domain of E-Cadherin for Heterophilic Adhesion with {alpha}E{beta}7, But Not for Homophilic Adhesion
J. Immunol., July 15, 2005; 175(2): 1014 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. J. Harrison, E. M. Corps, T. Berge, and P. J. Kilshaw
The mechanism of cell adhesion by classical cadherins: the role of domain 1
J. Cell Sci., February 15, 2005; 118(4): 711 - 721.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Mareel and A. Leroy
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Physiol Rev, April 1, 2003; 83(2): 337 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ozawa
Lateral Dimerization of the E-cadherin Extracellular Domain Is Necessary but Not Sufficient for Adhesive Activity
J. Biol. Chem., May 24, 2002; 277(22): 19600 - 19608.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/33/30862    most recent
M101712200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corps, E.
Right arrow Articles by Kilshaw, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corps, E.
Right arrow Articles by Kilshaw, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement